Description
GLP-3 / Retatrutide
GLP-3 (Retatrutide) is a novel triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. Supplied in lyophilized form with independent HPLC verification and a Certificate of Analysis included with every order.
Research Applications
Retatrutide represents a new class of multi-receptor agonists studied in metabolic research. Its triple mechanism of action — activating GLP-1R for appetite regulation, GIPR for insulin sensitization, and GCGR for energy expenditure — makes it a breakthrough tool in obesity, diabetes, and metabolic syndrome research.
Available Sizes
- 30mg per vial
- 50mg per vial
Specifications
- Purity: ≥99%
- Form: Lyophilized powder
- Storage: -20°C recommended
For laboratory and research use only. Not for human consumption.


